Plasma Fractionation: Critical Driver Shaping the Elevated Demand For Plasma Fractionation Driven By The Escalating Burden Of Chronic Diseases Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Plasma Fractionation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the plasma fractionation market has seen robust growth. The size of the market is projected to increase from $31.42 billion in 2024 to $34.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the historic period include the increasing incidence of hemophilia and immunodeficiency disorders, a surge in the aging population, escalating demand for immunoglobulins, expansion of plasma donation centers, and a growth in the number of surgical procedures.

Plasma Fractionation Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the plasma fractionation market is set to witness rapid expansion, reaching $50.54 billion by 2029 with a compound annual growth rate (CAGR) of 10.3%. The growth during the projection period can be attributed to increased worldwide health care spending, expanding uses of plasma-derived medical products, soaring investment in research and development, utilization of plasma for treating neurological disorders, and the enlargement of plasma fractionation facilities. Noteworthy trends for the forecast span are the advent of novel fractionation technologies, transition towards albumin and immunoglobulin treatments, increasing demand for specialty plasma products, emphasis on pathogen inactivation technologies, and strategic collaborations and partnerships within the plasma industry.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

What Are the Drivers Transforming the Plasma Fractionation Market?
As chronic diseases continue to rise, their impact is expected to fuel the expansion of the plasma fractionation market. These diseases, defined as conditions lasting over a year requiring consistent medical care such as heart disease, cancer, and diabetes, could see a decline in morbidity and enhanced quality of life through plasma product treatments. This particular factor will also induce cost-effectiveness further creating an upward demand for plasma fractionation. For example, a January 2023 report from the National Library of Medicine in the US projected that the population of individuals over 50 with one or more chronic illnesses will reach 142.66 million by 2050, a 99.5% increase from 71.522 million in 2020. This escalating prevalence of chronic diseases is, thus, steering the progression of the healthcare analytical testing service market. Hence, it is anticipated that the growth of the plasma fractionation market will be driven by the soaring numbers of chronic diseases across different age groups.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What Are the Key Trends Driving Plasma Fractionation Market Growth?
Key market players are launching innovative technologies, including hi-tech procedures for converting donated human plasma into crucial medications, and using sophisticated technology to increase the efficiency and safety of the process. For instance, in March 2023, CSL Behring, a company based in Germany, inaugurated a new plasma fractionation facility that cost $470 million. This facility uses state-of-the-art technology to enhance the efficiency and safety of plasma processing, ensuring the production of higher quality and more dependable medicines. The increased production of these crucial medications meets the rising demand, ensuring that more patients can access life-saving treatments. The innovative automation and self-cleaning protocols lower the chance of contamination, improve overall hygiene standards, and further ensure patient safety.

Which Segments in the Plasma Fractionation Market Offer the Most Profit Potential?
The plasma fractionation market covered in this report is segmented -

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:
1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)
3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)
4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Which Firms Dominate the Plasma Fractionation Market by Market Share and Revenue in 2025?
Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Which Regions Offer the Highest Growth Potential in the Plasma Fractionation Market?
North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.